Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Chicago IL, St Louis MO, Detroit MI, Nashville TN,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Chicago IL, Ypsilanti MI, St Louis MO, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Chicago IL, Ypsilanti MI, Minneapolis MN, Kitchener,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase 3, Recruiting
Active & Responsive
Multi-Site Trial of Tirzepatide for Smoking Cessation
for
Smoking Cessation, Smoking Behaviors
Location: Chicago IL, New Haven CT, Aurora CO, Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 21 - 65
Code: NCT07602699
Phase 2, Recruiting
Active & Responsive
Cortical Recording and Stimulating Array Brain-Machine Interface
Get alerts for new trials in your area by subscribing now
Active & Responsive
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
for
Ovarian Cancer, Fallopian Tube Cancer
Location: Chicago IL, St Louis MO, Rochester MN, Durham NC,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05287451
Recruiting
Active & Responsive
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Chicago IL, Madison WI, Pittsburgh PA, Toronto,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 65
Code: NCT04786262
Phase 3, Recruiting
Active & Responsive
Tissue Destruction and Healing in Celiac Disease
for
Celiac Disease
Location: Chicago IL, Rochester MN
Sponsor: University of Chicago
Sex: All
Age: 18 - 70+
Code: NCT05680012
Recruiting
Active & Responsive
Intramedullary Calcium Sulfate Antibiotic Depot
for
Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures
Location: Chicago IL, Nashville TN, Roanoke VA, Winchester VA,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT05766670
Phase 3, Recruiting
Active & Responsive
Treatment of Moderate to Severe Refractory Crohn's Disease
for
Crohns Disease
Location: Chicago IL, Iowa City IA, Ann Arbor MI, St Louis MO,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18 - 65
Code: NCT06721962
Phase 1, Phase 2, Recruiting
Active & Responsive
STRIVE Post-Market Registry Study
for
Emphysema
Location: Chicago IL, Anderson SC, Hershey PA, Baltimore MD,
Location: Chicago IL, Athens GA, Dallas TX, Hartford CT,
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 60
Code: NCT04580134
Recruiting
Active & Responsive
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Chicago IL, Cincinnati OH, Lawrenceville GA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07571005
Phase 3, Recruiting
Active & Responsive
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Chicago IL, Birmingham AL, New York NY, Miami FL,
Sponsor: University of California, San Francisco
Sex: Female
Age: 30 - 70+
Code: NCT02620852
Recruiting
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository